secwatch.observer — SEC 8-K summary
======================================

Issuer:     KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS)
CIK:        0001877184
Form:       8-K
Filed at:   2025-03-07T23:59:59+00:00
Accession:  0001193125-25-049896
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 3.03, 5.03, 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Kestra Medical grants Kennedy Lewis and Perceptive warrants for 434,916 shares; adopts 2025 equity plan
--------------------------------------------------------------------------------

- Issued three warrants to Kennedy Lewis Capital Partners and Perceptive Credit Holdings to purchase 434,916 common shares at $17.81 per share, exercisable until Dec 28, 2030.
- Warrants replace a prior warrant to Kennedy Lewis and are subject to a 180-day lock-up from March 7, 2025.
- Adopted the 2025 Omnibus Incentive Plan, authorizing grants of options, RSUs, and other share-based awards to employees, officers, and directors.
- Increased authorized share capital to $100M, divided into 100M common shares; ordinary shares redesignated as common shares.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1877184/000119312525049896/0001193125-25-049896-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1877184/000119312525049896/d890644d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-049896

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer